Xigen Is A Clinical Phase Biopharmaceutical Company Developing Anti Inflammatory Peptide Based Therapeutics Expected To Capture Market Share From Both Anti Tnf Biologics And Steroids The Company Is Uniquely Positioned To Exploit Know How On The Targeted Cellular Delivery Of Optimised Peptide Based Products Or Small Molecules Employing Proprietary Carrier Motifs
No conferences found for this company.
| Company Name | Xigen Sa |
| Country |
Switzerland
|
| Address | N/A |
| Telephone | N/A |
| N/A |
